Effects of gelatine and medium molecular weight starch as priming fluid in cardiopulmonary bypass: a randomised controlled trial

WW Yap, D Young, V Pathi

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Perioperative volume replacement after cardiopulmonary bypass is complicated by post-bypass systemic inflammatory process. The aim of this study was to assess the effects of using two different colloid solutions as priming fluids in cardiopulmonary bypass. The study's primary end point was to measure the amount of fluid replacement needed during and post-cardiopulmonary bypass; blood loss, change in blood profile and intraocular pressure were secondary end points, used as measures of plasma oncotic pressures. Patients undergoing coronary artery bypass grafting were recruited. Both patients and surgeons were blinded to receive either Gelofusine® or Voluven® as priming fluids. At fixed intervals during cardiopulmonary bypass, the patients had their intraocular pressures measured. Intra and postoperafive fluid replacement was in the form of 4.5% human albumin and the amount was recorded for each subject. The result did not show any significant differences in the amount of fluid needed to be replaced, in blood loss or in blood profile between the two groups. However, it showed an increase in intraocular pressure in both groups once cardiopulmonary bypass commenced. The average intraocular pressure was higher in the Gelofusine® group compared to the Voluven® group. The significant increase in intraocular pressure measurements in the Gelofusine® group compared to the Voluven® group support the hypothesis that Voluven maintains the plasma oncotic pressure better and reduces fluid shift.

LanguageEnglish
Pages57-62
Number of pages6
JournalPerfusion
Volume22
Issue number1
DOIs
Publication statusPublished - 1 Jan 2007

Fingerprint

Cardiopulmonary Bypass
Starch
Intraocular Pressure
Polygeline
Randomized Controlled Trials
Molecular Weight
Molecular weight
Fluids
Blood
Group
Fluid Shifts
Pressure
Plasmas
Colloids
Coronary Artery Bypass
Pressure measurement
Albumins
Blood Pressure
HES 130-0.4

Keywords

  • cardiopulmonary bypass
  • colloid solutions
  • artery bypass grafting

Cite this

@article{e75e2224ef344d1bbb2c992af4c44b8a,
title = "Effects of gelatine and medium molecular weight starch as priming fluid in cardiopulmonary bypass: a randomised controlled trial",
abstract = "Perioperative volume replacement after cardiopulmonary bypass is complicated by post-bypass systemic inflammatory process. The aim of this study was to assess the effects of using two different colloid solutions as priming fluids in cardiopulmonary bypass. The study's primary end point was to measure the amount of fluid replacement needed during and post-cardiopulmonary bypass; blood loss, change in blood profile and intraocular pressure were secondary end points, used as measures of plasma oncotic pressures. Patients undergoing coronary artery bypass grafting were recruited. Both patients and surgeons were blinded to receive either Gelofusine{\circledR} or Voluven{\circledR} as priming fluids. At fixed intervals during cardiopulmonary bypass, the patients had their intraocular pressures measured. Intra and postoperafive fluid replacement was in the form of 4.5{\%} human albumin and the amount was recorded for each subject. The result did not show any significant differences in the amount of fluid needed to be replaced, in blood loss or in blood profile between the two groups. However, it showed an increase in intraocular pressure in both groups once cardiopulmonary bypass commenced. The average intraocular pressure was higher in the Gelofusine{\circledR} group compared to the Voluven{\circledR} group. The significant increase in intraocular pressure measurements in the Gelofusine{\circledR} group compared to the Voluven{\circledR} group support the hypothesis that Voluven maintains the plasma oncotic pressure better and reduces fluid shift.",
keywords = "cardiopulmonary bypass , colloid solutions, artery bypass grafting",
author = "WW Yap and D Young and V Pathi",
year = "2007",
month = "1",
day = "1",
doi = "10.1177/0267659107077903",
language = "English",
volume = "22",
pages = "57--62",
journal = "Perfusion",
issn = "0267-6591",
number = "1",

}

Effects of gelatine and medium molecular weight starch as priming fluid in cardiopulmonary bypass : a randomised controlled trial. / Yap, WW; Young, D; Pathi, V.

In: Perfusion, Vol. 22, No. 1, 01.01.2007, p. 57-62.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Effects of gelatine and medium molecular weight starch as priming fluid in cardiopulmonary bypass

T2 - Perfusion

AU - Yap, WW

AU - Young, D

AU - Pathi, V

PY - 2007/1/1

Y1 - 2007/1/1

N2 - Perioperative volume replacement after cardiopulmonary bypass is complicated by post-bypass systemic inflammatory process. The aim of this study was to assess the effects of using two different colloid solutions as priming fluids in cardiopulmonary bypass. The study's primary end point was to measure the amount of fluid replacement needed during and post-cardiopulmonary bypass; blood loss, change in blood profile and intraocular pressure were secondary end points, used as measures of plasma oncotic pressures. Patients undergoing coronary artery bypass grafting were recruited. Both patients and surgeons were blinded to receive either Gelofusine® or Voluven® as priming fluids. At fixed intervals during cardiopulmonary bypass, the patients had their intraocular pressures measured. Intra and postoperafive fluid replacement was in the form of 4.5% human albumin and the amount was recorded for each subject. The result did not show any significant differences in the amount of fluid needed to be replaced, in blood loss or in blood profile between the two groups. However, it showed an increase in intraocular pressure in both groups once cardiopulmonary bypass commenced. The average intraocular pressure was higher in the Gelofusine® group compared to the Voluven® group. The significant increase in intraocular pressure measurements in the Gelofusine® group compared to the Voluven® group support the hypothesis that Voluven maintains the plasma oncotic pressure better and reduces fluid shift.

AB - Perioperative volume replacement after cardiopulmonary bypass is complicated by post-bypass systemic inflammatory process. The aim of this study was to assess the effects of using two different colloid solutions as priming fluids in cardiopulmonary bypass. The study's primary end point was to measure the amount of fluid replacement needed during and post-cardiopulmonary bypass; blood loss, change in blood profile and intraocular pressure were secondary end points, used as measures of plasma oncotic pressures. Patients undergoing coronary artery bypass grafting were recruited. Both patients and surgeons were blinded to receive either Gelofusine® or Voluven® as priming fluids. At fixed intervals during cardiopulmonary bypass, the patients had their intraocular pressures measured. Intra and postoperafive fluid replacement was in the form of 4.5% human albumin and the amount was recorded for each subject. The result did not show any significant differences in the amount of fluid needed to be replaced, in blood loss or in blood profile between the two groups. However, it showed an increase in intraocular pressure in both groups once cardiopulmonary bypass commenced. The average intraocular pressure was higher in the Gelofusine® group compared to the Voluven® group. The significant increase in intraocular pressure measurements in the Gelofusine® group compared to the Voluven® group support the hypothesis that Voluven maintains the plasma oncotic pressure better and reduces fluid shift.

KW - cardiopulmonary bypass

KW - colloid solutions

KW - artery bypass grafting

UR - http://www.scopus.com/inward/record.url?scp=34347388218&partnerID=8YFLogxK

U2 - 10.1177/0267659107077903

DO - 10.1177/0267659107077903

M3 - Article

VL - 22

SP - 57

EP - 62

JO - Perfusion

JF - Perfusion

SN - 0267-6591

IS - 1

ER -